← Leaderboards
Bryan P Toole
Tufts University Boston
$5,987,863
Attributed
$5,987,863
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $500.3K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$5,987,863 · 4
By mechanism
R01$5,511,891 · 3
T32$475,972 · 1
Top collaborators
No co-investigators on record.
Most similar at Tufts University Boston
Same institution · by research overlap
- Claire L Moore$27,539,168
- Ana Soto$12,807,156
- Ralph R Isberg$26,185,490
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellProtein Structure FunctionMetastasisHyaluronateApoptosisIn VivoCell Cell InteractionLaboratory MouseGlycoproteinsEnzyme Induction /RepressionCell BehaviorAbbreviationsHepatocyte Growth FactorAthymic MouseCellsCharacteristicsCell CommunicationCell SurvivalCancer CellCancer PatientAnchorage-Independent GrowthCd44 AntigensApoptoticConnective Tissue Cells
Grant awards (24)
Perturbation of hyaluronan function in cancer$251,120
R01 · FY2010 · CA · contact PI
Perturbation of hyaluronan function in cancer$251,120
R01 · FY2009 · CA · contact PI
Perturbation of hyaluronan function in cancer$251,120
R01 · FY2008 · CA · contact PI
Inhibition of Tumor Progression by Hyaluronan Oligomers$249,182
R01 · FY2008 · CA · contact PI
Perturbation of hyaluronan function in cancer$251,120
R01 · FY2007 · CA · contact PI
Inhibition of Tumor Progression by Hyaluronan Oligomers$249,182
R01 · FY2007 · CA · contact PI
Inhibition of Tumor Progression by Hyaluronan Oligomers$256,624
R01 · FY2006 · CA · contact PI
Inhibition of Tumor Progression by Hyaluronan Oligomers$262,800
R01 · FY2005 · CA
TUMOR CELL STROMAL INTERACTIONS IN CANCER$308,796
R01 · FY2004 · CA
Inhibition of Tumor Progression by Hyaluronan Oligomers$262,800
R01 · FY2004 · CA
TUMOR CELL STROMAL INTERACTIONS IN CANCER$279,651
R01 · FY2003 · CA
PERTURBATION OF HYALURONAN FUNCTION IN CANCER$250,885
R01 · FY2003 · CA
TUMOR CELL STROMAL INTERACTIONS IN CANCER$65,840
R01 · FY2003 · CA
TUMOR CELL STROMAL INTERACTIONS IN CANCER$337,539
R01 · FY2002 · CA
PERTURBATION OF HYALURONAN FUNCTION IN CANCER$280,254
R01 · FY2002 · CA
TRAINING PROGRAM IN DEVELOPMENTAL BIOLOGY$168,143
T32 · FY2002 · HD
TUMOR CELL STROMAL INTERACTIONS IN CANCER$329,820
R01 · FY2001 · CA
PERTURBATION OF HYALURONAN FUNCTION IN CANCER$273,731
R01 · FY2001 · CA
INHIBITION OF TUMOR PROGESSION BY HYALURONAN OLIGOMERS$249,700
R01 · FY2001 · CA
TRAINING PROGRAM IN DEVELOPMENTAL BIOLOGY$166,450
T32 · FY2001 · HD
TUMOR CELL STROMAL INTERACTIONS IN CANCER$339,721
R01 · FY2000 · CA
PERTURBATION OF HYALURONAN FUNCTION IN CANCER$267,402
R01 · FY2000 · CA
INHIBITION OF TUMOR PROGESSION BY HYALURONAN OLIGOMERS$243,484
R01 · FY2000 · CA
TRAINING PROGRAM IN DEVELOPMENTAL BIOLOGY$141,379
T32 · FY2000 · HD